Estrogen inhibits D2S receptor-regulated Gi3 and Gs protein interactions to stimulate prolactin production and cell proliferation in lactotropic cells

Journal of Endocrinology

Volumn 214, Issue 1, 2012, Pages 67-78

  Sengupta, A ^a   Sarkar, D K ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR SHORT ISOFORM; DOPAMINE D2 RECEPTOR L ISOFORM; ESTROGEN; G PROTEIN GQ11; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; ISOPROTEIN; MESSENGER RNA; PERTUSSIS TOXIN; PROLACTIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; HYPOPHYSIS CELL; NONHUMAN; PRIORITY JOURNAL; PROLACTIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGENS; FEMALE; GENE EXPRESSION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; LACTOTROPHS; PERTUSSIS TOXIN; PROLACTIN; PROTEIN BINDING; PROTEIN ISOFORMS; RATS; RATS, INBRED F344; RECEPTORS, DOPAMINE D2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 84864313590     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0125     Document Type: Article

References (42)

1. Albert PR 2002 G protein preferences for dopamine D2 inhibition of prolactin secretion and DNA synthesis in GH4 pituitary cells. Molecular Endocrinology 16 1903-1911.
2. Baertschi AJ, Audigier Y, Lledo PM, Israel JM, Bockaert J & Vincent JD 1992 Dialysis of lactotropes with antisense oligonucleotides assigns guanine nucleotide binding protein subtypes to their channel effectors. Molecular Endocrinology 6 2257-2265.
3. Baldwin JM 1994 Structure and function of receptors coupled to G proteins. Current Opinion in Cell Biology 6 180-190.
4. Ben-Jonathan N & Hnasko R 2001 Dopamine as a prolactin (PRL) inhibitor. Endocrine Reviews 22 724-763.
5. Bokoch GM, Katada T, Northup JK, Hewlett EL & Gilman AG 1983 Identification of the predominant substrate for ADP-ribosylation by islet activating protein. Journal of Biological Chemistry 258 2072-2075.
6. Bosse R, Fumagalli F, Jaber M, Giros B, Gainetdinov RR, Wetsel WC, Missale C & Caron MG 1997 Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron 19127-19138.
7. Burris TP & Freeman ME 1993 Low concentrations of dopamine increase cytosolic calcium in lactotrophs. Endocrinology 133 63-68.
8. Burris TP & Freeman ME 1994 Comparison of the forms of the dopamine D2 receptor expressed in GH4C1 cells. Proceedings of the Society for Experimental Biology and Medicine 205 226-335.
9. Caccavelli L, Feron F, Morange I, Rouer E, Benarous R, Dewailly D, Jaquet P, Kordon C & Enjalbert A 1994 Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine-resistant prolactinomas. Neuroendocrinology 60 314-322.
10. Caporali S, Imai M, Altucci L, Cancemi M, Caristi S, Cicatiello L, Matarese F, Penta R, Sarkar DK, Bresciani F et al. 2003 Distinct signaling pathways mediate stimulation of cell cycle progression and prevention of apoptotic cell death by estrogen in rat pituitary tumor PR1 cells. Molecular Biology of the Cell 14 5051-5059.
11. Chaturvedi K & Sarkar DK 2008 Alteration in G proteins and prolactin levels in pituitary after ethanol and estrogen treatment. Alcoholism, Clinical and Experimental Research 32 806-813.
12. Chun T-Y, Gregg D, Sarkar DK & Gorski J 1998 Differential regulation by estrogens of growth and prolactin synthesis in pituitary cells suggests that only a small pool of estrogen receptors is required for growth. PNAS 95 2325-2330.
13. Civelli O, Bunzow JR & Grandy DK 1993 Molecular diversity of the dopamine receptors. Annual Review of Pharmacology and Toxicology 33 281-307.
14. Cristina C, García-Tornadú I, Díaz-Torga G, Rubinstein M, Low MJ, Becú-Villalobos D, García-Tornadú I, Díaz-Torga G, Rubinstein M, Low MJ & Becú-Villalobos D 2006 Dopaminergic D2 receptor knockout mouse: an animal model of prolactinoma. Frontiers of Hormone Research 35 50-63.
15. Enjalbert A & Bockaert J 1983 Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary. Molecular Pharmacology 23 576-584.
16. Freeman ME, Kanyicska B, Lerant A & Nagy G 2000 Prolactin: structure, function, and regulation of secretion. Physiological Reviews 80 1523-1631.
17. Gershengorn MC & Osman R 1996 Molecular and cellular biology of thyrotropin-releasing hormone receptors. Physiological Reviews 76 175-191.
18. Ghahremani MH, Cheng P, Lembo PMC & Albert PR 1999 Distinct roles for Gai2, Gai3, and Gbg in modulation of forskolin- or Gs-mediated cAMP accumulation and calcium mobilization by dopamine D2S receptors. Journal of Biological Chemistry 274 9238-9245.
19. Guiramand J, Montmayeur JP, Ceraline J, Bhatia M & Borrelli E 1995 Alternative splicing of the dopamine D2 receptor directs specificity of coupling to G-proteins. Journal of Biological Chemistry 270 7354-7358.
20. Guivarc'h D, Vincent JD & Vernier P 1998 Alternative splicing of the D2 dopamine receptor messenger ribonucleic acid is modulated by activated sex steroid receptors in the MMQ prolactin cell line. Endocrinology 139 4213-4221.
21. Hentges S, Boyadjieva N & Sarkar DK 2000 Transforming growth factor-b3 stimulates lactotrope cell growth by increasing basic fibroblast growth factor from folliculo-stellate cells. Endocrinology 141 859-867.
22. Hnasko TS, Hnasko RM, Sotak BN, Kapur RP & Palmiter RD 2007 Genetic disruption of dopamine production results in pituitary adenomas and severe prolactinemia. Neuroendocrinology 86 48-57.
23. Kelly MA, Rubinstein M, Asa SL, Zhang G, Saez C, Bunzow JR, Allen RG, Hnasko R, Ben-Jonathan N, Grandy DK et al. 1997 Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron 19 103-113.
24. Kineman RD, Gettys TW & Frawley LS 1996 Role of guanine nucleotidebinding proteins, Gi alpha 3 and Gs alpha, in dopamine and thyrotropinreleasing hormone signal transduction: evidence for competition and commonality. Journal of Endocrinology 148 447-455.
25. Laccarino C, Samad TK, Mathis C, Kercret H, Picetti R & Borrelli E 2002 Control of lactotroph proliferation by dopamine: essential role of signalling through D2 receptors ERKs. PNAS 99 14530-14535.
26. Livingstone JD, Lerant A & Freeman ME 1998 Ovarian steroids modulate responsiveness to dopamine and expression of G-proteins in lactotropes. Neuroendocrinology 68 172-179.
27. Martinez de la Escalera G, Guthrie J & Weiner RI 1988 Transient removal of dopamine potentiates the stimulation of prolactin release by TRH but not VIP: stimulation via Ca2C/protein kinase C pathway. Neuroendocrinology 47 38-45.
28. Maurer RA 1989 Both isoforms of the cAMP-dependent protein kinase catalytic subunit can activate transcription of the prolactin gene. Journal of Biological Chemistry 264 6870-6873.
29. Oomizu S, Boyadjieva N & Sarkar DK 2003 Ethanol and estradiol modulate alternative splicing of dopamine D2 receptor mRNA and abolish the inhibitory action of bromocriptine on prolactin release from the pituitary gland. Alcoholism, Clinical and Experimental Research 27 975-980.
30. Pastorcic M, De A, Boyadjieva N, Vale W & Sarkar DK 1995 Reduction in the expression and action of transforming growth factor beta 1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary. Cancer Research 55 4892-4898.
31. Saiardi A, Bozzi Y, Baik JH & Borrelli E 1997 Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia. Neuron 19 115-126.
32. Sarkar DK 2006 Genesis of prolactinomas: studies using estrogen-treated animals. Frontiers of Hormone Research 35 32-49.
33. Sarkar DK, Gottschall PE & Meites J 1982 Damage to hypothalamic dopaminergic neurons is associated with development of prolactinsecreting pituitary tumors. Science 218 684-686.
34. Sarkar DK, Chaturvedi K, Oomizu S, Boyadjieva NI & Chen CP 2005 Dopamine, dopamine D2 receptor short isoform, transforming growth factor (TGF)-beta1, and TGF-beta type II receptor interact to inhibit the growth of pituitary lactotropes. Endocrinology 146 4179-4188.
35. Strange PG 1999 Agonism and inverse agonism at dopamine D2-like receptor. Clinical and Experimental Pharmacology & Physiology. Supplement 26 53-59.
36. Radl DB, Ferraris J, Boti V, Seilicovich A, Sarkar DK & Pisera D 2011 Dopamine-induced apoptosis of lactotropes is mediated by the short isoform of D2 receptor. PLoS ONE 6 e18097.
37. Usiello A, Baik JH, Rougé-Pont F, Picetti R, Dierich A, LeMeur M, Piazza PV & Borrelli E 2000 Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408 199-203.
38. Vallar L & Meldolesi J 1989 Mechanisms of signal transduction at the dopamine D2 receptor. Trends in Pharmacological Sciences 10 74-77.
39. Wang Y, Xu R, Sasaoka T, Tonegawa S, Kung MP & Sankoorikal EB 2000 Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions. Journal of Neuroscience 20 8305-8314.
40. Wiens BL, Nelson CS & Neve KA 1998 Contribution of serine residues to constitutive and agonist-induced signaling via the D2S dopamine receptor: evidence for multiple, agonist-specific active conformations. Molecular Pharmacology 54 435-444.
41. Wu ZB, Li CZ, Zong XY, Su ZP, Zeng YJ & Zhang YZ 2009 Correlation of alternative splicing of the D2 dopamine receptor mRNA and estrogen receptor mRNA in the prolactinomas and gonadotrope tumors. Journal of Neuro-Oncology 94 135-139.
42. Xu R, Parlow AF & Wang Y 2002 The effects of dopamine and D2 receptor antagonists on pituitary hormone secretion are intact in mice lacking dopamine D2L receptor. Brain Research 939 95-99.